NEW YORK--(BUSINESS WIRE)--VB Spine has received FDA Breakthrough Device Designation for a new blood test designed to identify patients at risk for scoliosis progression.
VB Spine Announces FDA Breakthrough Device Designation for New Blood Test Designed to Identify Patients at Risk for Scoliosis Progression
